Imidazolidines as new anti-Trypanosoma cruzi agents: Biological evaluation and structure–activity relationships
- 1 March 2008
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 16 (5), 2226-2234
- https://doi.org/10.1016/j.bmc.2007.11.077
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The future of Chagas disease controlTrends in Parasitology, 2006
- Synthesis, spectroscopic and biological properties of bis(3-arylimidazolidinyl-1)methanes. A novel family of antimicrobial agentsEuropean Journal of Medicinal Chemistry, 2005
- Specific chemotherapy of Chagas disease: controversies and advancesTrends in Parasitology, 2003
- Chemotherapy of Chagas' disease: status and new developments.Current Topics in Medicinal Chemistry, 2002
- The impact of Chagas disease control in Latin America: a reviewMemórias do Instituto Oswaldo Cruz, 2002
- Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2002
- Synthesis of novel tetrahydroimidazole derivatives and studies for their biological propertiesEuropean Journal of Medicinal Chemistry, 2001
- Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compoundsBioorganic & Medicinal Chemistry Letters, 2000
- Identification and Biosynthesis of N1,N9‐Bis(Glutathionyl)Aminopropylcadaverine (Homotrypanothione) in Trypanosoma CruziEuropean Journal of Biochemistry, 1994
- Perfluoroalkyl carbonyl compounds. 1. Perfluoroaldehyde and perfluorocarboxylic acid derivativesJournal of Medicinal Chemistry, 1970